We are live on
!
Find out more
CC
Colrain Capital Portfolio holdings
AUM
$259M
1-Year Est. Return
63.6%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+63.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$46M
(+35%)
Cap. Flow
+$35.6M
Cap. Flow
% of AUM
20.25%
Top 10 Holdings %
Top 10 Hldgs %
67.87%
Holding
23
New
–
Increased
21
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$15.9M |
| 2 |
Comcast
CMCSA
|
+$3.68M |
| 3 |
Cigna
CI
|
+$3.43M |
| 4 |
Antero Resources
AR
|
+$3.05M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$2.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$12.6M |
| 2 |
Vistra
VST
|
+$3.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 20.53% |
| 2 | Healthcare | 19.94% |
| 3 | Energy | 17.27% |
| 4 | Technology | 10.5% |
| 5 | Communication Services | 10.33% |
Similar funds
NAM
CCAM
QP
BFA
PW
BFP
TC
FC
Colrain Capital's Q3 2025 Portfolio in Review
As of Q3 2025, Colrain Capital held 23 positions worth $176M, up 35% from $130M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Colrain Capital deployed $35.6M of net new capital in Q3 2025, adding to 21 existing holdings.
By sector, the portfolio is most concentrated in Materials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Vistra, an estimated $3.16M trimmed.
- Colrain Capital added most to Chevron in Q3 2025, an estimated $15.9M increase.
- Colrain Capital's biggest Q3 2025 reduction was Vistra, cutting an estimated $3.16M.
- Colrain Capital fully exited Hess in Q3 2025, selling an estimated $12.6M.
- Colrain Capital's ten largest holdings make up 68% of its $176M portfolio in Q3 2025.
- Colrain Capital opened 0 new positions and closed 1 in Q3 2025.
- Colrain Capital's portfolio value rose 35% quarter-over-quarter to $176M.
Based on Colrain Capital's 13F filing for Q3 2025, filed 7 Nov 2025.